Premium
UPDATED SAFETY AND EFFICACY RESULTS OF «HLMoscow 1‐3» STUDY FOR THE 147 UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA
Author(s) -
Tumyan G.,
Kichigina M.,
Paramonova E.,
Medvedovskaya E.,
Trofimova O.,
Ryabuhina Y.,
Demina E.,
Zeynalova P.,
Kolomeytsev O.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.169_2631
Subject(s) - medicine , abvd , copp , bleomycin , radiation therapy , adverse effect , nuclear medicine , regimen , oncology , surgery , chemotherapy , vincristine , cyclophosphamide , heme , biochemistry , chemistry , heme oxygenase , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom